相似文献
1
The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization.
J Assist Reprod Genet. 1997 Jan;14(1):1-4. doi: 10.1007/BF02765740.
2
The treatment of patients with polycystic ovaries undergoing IVF.
J Assist Reprod Genet. 1997 Jan;14(1):12-4. doi: 10.1007/BF02765744.
3
Treatment of polycystic ovary patients undergoing IVF.
J Assist Reprod Genet. 1997 Jan;14(1):10-2. doi: 10.1007/BF02765743.
4
Gonadotropins in polycystic ovarian syndrome.
Ann N Y Acad Sci. 1993 May 28;687:150-61. doi: 10.1111/j.1749-6632.1993.tb43863.x.
5
The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme.
Hum Reprod. 1994 Sep;9(9):1596-9. doi: 10.1093/oxfordjournals.humrep.a138758.
6
Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome.
Best Pract Res Clin Obstet Gynaecol. 2016 Nov;37:80-97. doi: 10.1016/j.bpobgyn.2016.03.005. Epub 2016 Apr 1.
7
In vitro fertilization treatment in patients with polycystic ovaries.
J Assist Reprod Genet. 1997 Jan;14(1):7-10. doi: 10.1007/BF02765742.
8
Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization.
Fertil Steril. 2010 Jun;94(1):198-204. doi: 10.1016/j.fertnstert.2009.03.004. Epub 2009 Apr 9.
9
A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.
N Engl J Med. 1989 May 11;320(19):1233-7. doi: 10.1056/NEJM198905113201902.
10
Absence of predictive value of follicular inhibin on the results of human in vitro fertilization.
Fertil Steril. 1986 Aug;46(2):325-7. doi: 10.1016/s0015-0282(16)49535-x.
引用本文的文献
1
Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent Fertilization/Intracytoplasmic Sperm Injection Cycles: Comparing With Short Protocol.
Front Physiol. 2022 Feb 11;12:744968. doi: 10.3389/fphys.2021.744968. eCollection 2021.
2
Polycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques-A Literature Review.
Adv Ther. 2018 Nov;35(11):1805-1815. doi: 10.1007/s12325-018-0810-1. Epub 2018 Oct 11.
3
Patients with polycystic ovary syndrome have successful embryo arrest.
Int J Clin Exp Med. 2015 Apr 15;8(4):6247-51. eCollection 2015.
4
Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.
Hum Reprod Update. 2011 Jan-Feb;17(1):17-33. doi: 10.1093/humupd/dmq032. Epub 2010 Jul 16.
本文引用的文献
1
The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
Hum Reprod. 1995 Oct;10(10):2545-9. doi: 10.1093/oxfordjournals.humrep.a135742.
2
A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program.
J Assist Reprod Genet. 1993 Jan;10(1):15-20. doi: 10.1007/BF01204435.
3
Polycystic ovarian disease (PCOD)--pregnancy rate and outcome in in vitro fertilization.
J Assist Reprod Genet. 1993 Jan;10(1):11-4. doi: 10.1007/BF01204434.
4
Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome.
Fertil Steril. 1993 Mar;59(3):527-31. doi: 10.1016/s0015-0282(16)55794-x.
5
Is endometrial development in the peri-implantation period influenced by high concentrations of luteinizing hormone in the follicular phase?
Hum Reprod. 1993 Jul;8(7):1021-4. doi: 10.1093/oxfordjournals.humrep.a138186.
6
Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage.
Hum Reprod. 1993 Jun;8(6):829-33. doi: 10.1093/oxfordjournals.humrep.a138149.
7
Assisted reproduction techniques in polycystic ovarian syndrome.
Ann N Y Acad Sci. 1993 May 28;687:280-7. doi: 10.1111/j.1749-6632.1993.tb43877.x.
8
Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle.
Hum Reprod. 1993 May;8(5):695-8. doi: 10.1093/oxfordjournals.humrep.a138122.
9
Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage.
Br J Obstet Gynaecol. 1993 Dec;100(12):1082-9. doi: 10.1111/j.1471-0528.1993.tb15170.x.
10
In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome.
Fertil Steril. 1993 Nov;60(5):858-63. doi: 10.1016/s0015-0282(16)56287-6.
Zotero 插件